JOHN SHARKEY: Open Payments
NPI 1912556002 · ENCINITAS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,100 in 64 payments from 12 companies in 2025. Trend: 2023 $2,197 · 2024 $1,660 · 2025 $1,100
Food & beverage: $1,041Education: $59
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 19 | $270 |
| PFIZER INC. | 7 | $227 |
| Regeneron Healthcare Solutions, Inc. | 14 | $213 |
| ABBVIE INC. | 13 | $163 |
| GENZYME CORPORATION | 3 | $67 |
| UCB, Inc. | 1 | $36 |
| Galderma Laboratories, L.P. | 2 | $36 |
| Lilly USA, LLC | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
Products named: TREMFYA, DUPIXENT, LITFULO, SKYRIZI, CIBINQO, LIBTAYO, Bimzelx, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
